TW202206080A - 預防及治療冠狀病毒感染的化合物及方法 - Google Patents

預防及治療冠狀病毒感染的化合物及方法 Download PDF

Info

Publication number
TW202206080A
TW202206080A TW110115949A TW110115949A TW202206080A TW 202206080 A TW202206080 A TW 202206080A TW 110115949 A TW110115949 A TW 110115949A TW 110115949 A TW110115949 A TW 110115949A TW 202206080 A TW202206080 A TW 202206080A
Authority
TW
Taiwan
Prior art keywords
acid
sars
compound
cov
antrodia
Prior art date
Application number
TW110115949A
Other languages
English (en)
Chinese (zh)
Inventor
羅吉孟
黃琤
郁彬 吳
梁惠如
林佩欣
江豪
邱韋中
Original Assignee
薩摩亞商吉亞生技控股股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 薩摩亞商吉亞生技控股股份有限公司 filed Critical 薩摩亞商吉亞生技控股股份有限公司
Publication of TW202206080A publication Critical patent/TW202206080A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW110115949A 2020-05-01 2021-05-03 預防及治療冠狀病毒感染的化合物及方法 TW202206080A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063018690P 2020-05-01 2020-05-01
US63/018,690 2020-05-01

Publications (1)

Publication Number Publication Date
TW202206080A true TW202206080A (zh) 2022-02-16

Family

ID=78292168

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110115949A TW202206080A (zh) 2020-05-01 2021-05-03 預防及治療冠狀病毒感染的化合物及方法

Country Status (7)

Country Link
US (1) US12433901B2 (https=)
EP (1) EP4142713A1 (https=)
JP (1) JP7805010B2 (https=)
CN (1) CN116568295B (https=)
AU (1) AU2021264554A1 (https=)
TW (1) TW202206080A (https=)
WO (1) WO2021222534A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI800146B (zh) * 2021-10-21 2023-04-21 北京大學深圳研究生院 魚針草酸用於製備抑制新型冠狀病毒與變異株等感染與複製之醫藥組合物的用途
TWI917417B (zh) 2020-07-23 2026-03-11 薩摩亞商吉亞生技控股股份有限公司 治療病毒感染之方法及組合物

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023535714A (ja) * 2020-07-23 2023-08-21 アージル・バイオテック・ホールディング・カンパニー・リミテッド ウイルス感染を阻害するための方法および組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140105928A1 (en) * 2004-01-06 2014-04-17 Paul Edward Stamets Antiviral and antibacterial activity from medicinal mushrooms
CA2481489A1 (en) * 2002-11-29 2004-06-17 Morinaga Milk Industry Co., Ltd. Cysteine protease inhibitor
TWI389699B (zh) * 2009-02-13 2013-03-21 高雄醫學大學 用於誘導細胞凋亡之樟芝子實體乙醇萃取物及其製備方法
US7919665B2 (en) 2009-02-17 2011-04-05 Conocophillips Company Mercury removal from hydrocarbons
TW201231474A (en) * 2011-01-26 2012-08-01 Univ Kaohsiung Medical Triterpenoid composition of Antrodia cinnamomea, preparation and analysis method thereof
FI126047B (en) * 2012-08-28 2016-06-15 John Eriksson Pharmaceutical compositions of anisomelic acid and their use
TWI453026B (zh) * 2013-05-14 2014-09-21 Jenisa Biotechnology Corp Ltd 魚針草萃取物及其純化物抗流感病毒之用途
US9645651B2 (en) 2013-09-24 2017-05-09 Microsoft Technology Licensing, Llc Presentation of a control interface on a touch-enabled device based on a motion or absence thereof
US11253527B2 (en) * 2019-02-25 2022-02-22 Arjil Biotech Holding Company Limited Method and composition for inhibiting virus infection
WO2021202982A1 (en) * 2020-04-03 2021-10-07 Turtle Bear Holdings, Llc Compositions and methods for modulating inflammatory response
CN113521060B (zh) * 2020-04-17 2022-12-06 北京大学深圳研究生院 鱼针草内酯抗新型冠状病毒的用途
TW202200175A (zh) * 2020-04-28 2022-01-01 浩峰生物科技股份有限公司 牛樟芝萃取物(Ant-Ex)減少血管收縮素轉換酶2(ACE-2)蛋白質表現

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI917417B (zh) 2020-07-23 2026-03-11 薩摩亞商吉亞生技控股股份有限公司 治療病毒感染之方法及組合物
TWI800146B (zh) * 2021-10-21 2023-04-21 北京大學深圳研究生院 魚針草酸用於製備抑制新型冠狀病毒與變異株等感染與複製之醫藥組合物的用途

Also Published As

Publication number Publication date
JP7805010B2 (ja) 2026-01-23
EP4142713A1 (en) 2023-03-08
US12433901B2 (en) 2025-10-07
WO2021222534A1 (en) 2021-11-04
US20210338690A1 (en) 2021-11-04
AU2021264554A1 (en) 2023-01-05
JP2023524274A (ja) 2023-06-09
CN116568295A (zh) 2023-08-08
CN116568295B (zh) 2026-02-13

Similar Documents

Publication Publication Date Title
US12485157B2 (en) Method of treating COVID-19
Chiou et al. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease
Zehra et al. Corona virus versus existence of human on the earth: A computational and biophysical approach
US7662860B2 (en) 3D-structure model of SARS coronavirus 3CL protease and anti-SARS drugs
KR20220146558A (ko) 항-코로나바이러스에서의 디설피람의 용도
CN113289018A (zh) 金诺芬等老药及其组合物在抗单正链rna病毒中的应用
CN113332363B (zh) 茶叶提取物及其组合物在抗冠状病毒中的应用
Hemmati et al. Mysterious virus: a review on behavior and treatment approaches of the novel coronavirus, 2019-nCoV
CN113262224A (zh) 奈非那韦在制备防治新冠肺炎药物中的应用
TW202206080A (zh) 預防及治療冠狀病毒感染的化合物及方法
JP2023525855A (ja) コロナウイルスによる疾患の治療及び／又は予防のための化合物及びその使用
CN1237184C (zh) 抗SARS－CoV药物作用靶标、药物筛选方法及抗SARS药物
TWI905258B (zh) 預防及治療病毒感染之化合物及方法
Pal et al. Compilation of potential protein targets for SARS-CoV-2: Preparation of homology model and active site determination for future rational antiviral design
US20210386725A1 (en) Method for inhibiting coronavirus infection and replication
CN113893345A (zh) 247种化合物及其组合物在抗新型冠状病毒感染中的应用
Singh et al. COVID-19: pathophysiology, transmission, and drug development for therapeutic treatment and vaccination strategies
Mondal et al. Evaluation of the binding affinity of anti-viral drugs against main protease of SARS-CoV-2 through a molecular docking study
TWI917417B (zh) 治療病毒感染之方法及組合物
US20230241067A1 (en) Targeting papain-like protease for broad-spectrum coronaviruses inhibition
US20250214981A1 (en) Compound and application thereof in preparation of medicine for treating enterovirus-related diseases
JP2023535714A (ja) ウイルス感染を阻害するための方法および組成物
RU2829731C1 (ru) Применение дисульфирама при резистентности коронавируса
Lianingsih In silico analysis of Trisindoline 1 compound against Mpro SARS-CoV-2 as novel potential drugs candidate
MAJUMDER et al. AJ Csian OURNALOF HEMISTRY AJ Csian OURNALOF HEMISTRY